IsoPlexis IPO

IsoPlexis is building solutions to accelerate the development of curative medicines and personalized therapeutics.

Register for Details

For more details on financing and valuation for IsoPlexis, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is IsoPlexis's ticker symbol?


What is IsoPlexis's stock price?

0.741 as of 3/17/23

IsoPlexis Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
1/7/2021 Series D $92.5MM raised $XXX.XX $XXX.XX
1/9/2020 Series C and C-2 $50MM raised $XXX.XX $XXX.XX
9/26/2017 Series B and B-2 $13.68MM raised $XXX.XX $XXX.XX
5/28/2015 Series A-2 $3.69MM raised $XXX.XX $XXX.XX
7/6/2014 Series A $1.65MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about IsoPlexis

Forge green plus iconForge green minus icon

What is IsoPlexis funding to date?

IsoPlexis has raised $161.52MM with the following series:
$1.65MM raised for Series A,$3.69MM raised for Series A-2,$13.68MM raised for Series B and B-2,$50MM raised for Series C and C-2,$92.5MM raised for Series D.
Forge green plus iconForge green minus icon

When was IsoPlexis founded?

IsoPlexis was founded in 2013.